血常规参数对转移性胃癌患者的预后分析
Prognostic Significance of the Bloodcell Parameters in Patients with Metastatic Gastric Cancer
DOI: 10.12677/ACM.2020.107199, PDF,    国家自然科学基金支持
作者: 赵光辉, 丁爱萍, 于国红, 李 晖, 马英骥, 梁志威, 邱文生*:青岛大学附属医院肿瘤科,山东 青岛
关键词: 胃癌血常规参数预后Gastric Cancer Hematological Indicators Prognosis
摘要: 目的:本研究探讨中性粒细胞与淋巴细胞比值(NLR)及血小板与淋巴细胞比值(PLR)与转移性胃癌(metastatic gastric carcer, mGC)患者临床病例特征关系及预后的影响。方法:本文采用回顾性统计分析方法,搜集我院的110例确诊为IV期转移性胃癌的患者的临床病理特征。统计分析在SPSS 24.0统计软件中进行。用Kaplan-Meier方法绘制总生存期(OS, Overall Survival)、无进展生存期(PFS, Progression Free Survival)与NLR、PLR的关系。Cox比例危险度模型评价OS、PFS的相关危险因素。结果:低NLR组的OS和PFS均高于高NLR组,低PLR组的OS和PFS均高于高PLR组。高NLR和腹膜转移是OS的独立危险因素。高NLR和高PLR是PFS的独立危险因素。结论:NLR与胃癌患者的较差的临床病理特征相关,且是OS、PFS独立预后危险因素。此外,PLR是PFS的独立危险因素。
Abstract: Objective: The purpose of this study was to evaluate the significance of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) on the prognosis of metastatic gastric cancer (GC). This was a retrospective review of 110 patients were at presentation diagnosed with stage IV metastatic GC and all patients received palliative chemotherapy between January 2012 and January 2016 at the Affiliated Hospital of Qingdao University. Pretreatment NLR and PLR, as well as clinicopathological characteristics were collected. Patients were divided into high and low groups according to the cutoff values for NLR and PLR. The Kaplan-Meier method was applied to estimate the overall survival (OS) and progress free survival (PFS) the Cox proportional hazards model to evaluate the related risk factors for OS. All tests were 2-tailed and a P < 0.05 was considered to indicate a statistically significant difference. Results: Patients with high NLR and high PLR had poor overall survival compared with those who had low NLR and low PLR. Our multivariate analysis had indicated that high NLR and peritoneal metastasis was independent prognostic factors for overall survival; however, the PLR was not shown to be an independent prognostic factor. Conclusions: NLR is related to the poor clinicopathological characteristics of gastric cancer patients, and is an independent prognostic risk factor for OS and PFS. PLR is an independent risk factor for PFS.
文章引用:赵光辉, 丁爱萍, 于国红, 李晖, 马英骥, 梁志威, 邱文生. 血常规参数对转移性胃癌患者的预后分析[J]. 临床医学进展, 2020, 10(7): 1312-1323. https://doi.org/10.12677/ACM.2020.107199

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. [Google Scholar] [CrossRef
[3] Liu, G., Ke, L.C. and Sun, S.R. (2018) Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Patients with Soft Tissue Sarcoma: A Meta-Analysis. Medicine (Baltimore), 97, e12176. [Google Scholar] [CrossRef
[4] Diem, S., Schmid, S., Krapf, M., et al. (2017) Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab. Lung Cancer, 111, 176-181. [Google Scholar] [CrossRef] [PubMed]
[5] Cha, Y.J., Park, E.J., Baik, S.H., et al. (2019) Clinical Significance of Tumor-Infiltrating Lymphocytes and Neutrophil-to-Lymphocyte Ratio in Patients with Stage III Colon Cancer Who Underwent Surgery Followed by FOLFOX Chemotherapy. Scientific Reports, 9, Article No. 11617. [Google Scholar] [CrossRef] [PubMed]
[6] Ozer-Stillman, I., Strand, L., Chang, J., et al. (2014) Meta-Analysis for the Association between Overall Survival and Progression-Free Survival in Gastrointestinal Stromal Tumor. Clinical Cancer Research, 21, 295-302. [Google Scholar] [CrossRef
[7] Schwartz, L.H., Litière, S., de Vries, E., et al. (2016) RECIST 1.1—Update and Clarification: From the RECIST Committee. European Journal of Cancer, 62, 132-137. [Google Scholar] [CrossRef] [PubMed]
[8] Kim, Y.J., Chung, W.C., Youn, G.J., et al. (2019) The Predictive Factors of Gastric Cancer Recurrence after the Completion of Adjuvant Chemotherapy in Advanced Gastric Cancer. Revista Espanola de Enfermedades Digestivas, 111, 537-542. [Google Scholar] [CrossRef] [PubMed]
[9] Jin, H., Zhang, G., Liu, X., et al. (2013) Blood Neutrophil-Lymphocyte Ratio Predicts Survival for Stages III-IV Gastric Cancer Treated with Neoadjuvant Chemotherapy. World Journal of Surgical Oncology, 11, 112. [Google Scholar] [CrossRef] [PubMed]
[10] Shaul, M.E. and Fridlender, Z.G. (2017) Neutrophils as Active Regulators of the Immune System in the Tumor Microenvironment. Journal of Leukocyte Biology, 102, 343-349. [Google Scholar] [CrossRef
[11] Hoffmann, T.K., Dworacki, G., Tsukihiro, T., et al. (2002) Spontaneous Apoptosis of Circulating T Lymphocytes in Patients with Head and Neck Cancer and Its Clinical Importance. Clinical Cancer Research, 8, 2553-2562.
[12] Zheng, X., et al. (2017) Prognostic Role of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Meta-Analysis. Oncotarget, 8, 57386-57398. [Google Scholar] [CrossRef] [PubMed]
[13] Yu, X., Zhang, Z., Wang, Z., et al. (2016) Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis. Clinical and Translational Oncology, 18, 497-506. [Google Scholar] [CrossRef] [PubMed]
[14] Sa, R. (2001) Progress in Human Tumour Immunology and Immunotherapy. Nature, 411, 380-384. [Google Scholar] [CrossRef] [PubMed]
[15] Bambace, N.M. and Holmes, C.E. (2011) The Platelet Contribution to Cancer Progression. Journal of Thrombosis and Haemostasis, 9, 237-249. [Google Scholar] [CrossRef] [PubMed]
[16] Ma, X., Wang, Y., Sheng, H., et al. (2014) Prognostic Significance of Thrombocytosis, Platelet Parameters and Aggregation Rates in Epithelial Ovarian Cancer. Journal of Obstetrics and Gynaecology Research, 40, 178-183. [Google Scholar] [CrossRef] [PubMed]
[17] Menter, D.G., Tucker, S.C., Kopetz, S., et al. (2014) Platelets and Cancer: A Casual or Causal Relationship: Revisited. Cancer and Metastasis Reviews, 33, 231-269. [Google Scholar] [CrossRef] [PubMed]
[18] Sierko, E. and Wojtukiewicz, M.Z. (2004) Platelets and Angiogenesis in Malignancy. Seminars in Thrombosis and Hemostasis, 30, 95-108. [Google Scholar] [CrossRef] [PubMed]
[19] Pw, S. and Fr, B. (2003) Tumour Necrosis Factor Alpha: A Potential Target for the Therapy of Solid Tumours. The Lancet Oncology, 4, 565-573. [Google Scholar] [CrossRef
[20] Wang, J., Qu, J.L., Li, Z., et al. (2018) Pretreatment Platelet-to-Lymphocyte Ratio Is Associated with the Response to First-Line Chemotherapy and Survival in Patients with Metastatic Gastric Cancer. Journal of Clinical Laboratory Analysis, 32. [Google Scholar] [CrossRef] [PubMed]